New imaging technology detects early signs of heart disease through the skin
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 18:15 ET (31-May-2026 22:15 GMT/UTC)
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures. By revealing early signs of cardiovascular risk, this technology could help doctors intervene sooner, guide personalized therapies, and improve long-term heart health.
A Wits-led study published in the prestigious journal Nature has added whole-genome data from more than 1,000 people across nine African countries to global science, significantly expanding understanding of human genetic diversity. The research, led through the Assessing Genetic Diversity in Africa (AGenDA) project, is expected to uncover millions of novel genetic variants, improving how diseases such as cancer, mental illness, diabetes and heart disease are studied, predicted and treated.
By focusing on African populations historically underrepresented in genomic research, the project strengthens genome-wide association studies and provides a model for African-led data governance, ethical data sharing and community partnership. The findings will contribute to more accurate genetic research and precision medicine for African populations and beyond.
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis are marked by the buildup of misfolded proteins that slowly destroy brain cells, yet treatments that address this root cause are still lacking. Interestingly, researchers provide a comprehensive review of the role of heat shock protein 70 (Hsp70) molecular chaperones in several neurodegenerative diseases. Notably, Hsp70 exert neuroprotective effects and mitigate the occurrence of pathological protein aggregates.
A prospective phase I/II clinical trial led by QST Hospital reports that carbon-ion radiotherapy achieved five-year local control and disease-free survival rates of 92%, with no grade ≥2 toxicities, in selected patients with stage I breast cancer who did not undergo surgery. Excellent cosmetic outcomes were maintained. These findings position carbon-ion therapy as a promising alternative for medically inoperable patients or those who decline surgery and support the need for larger, controlled studies.
Hepatocellular carcinoma (HCC), characterized by high aggressiveness and recurrence, poses a significant global health challenge. The interplay between the tumour microenvironment and exogenous exposures disrupts homeostasis, and tumour biological behaviours, then accelerating tumour progression. Sorafenib, a first-line targeted therapy, often faces resistance due to tumour heterogeneity and microenvironmental changes. Understanding the link between adverse exposures and drug resistance, identifying key molecules, and developing precise interventions are crucial for improving the management of advanced/drug-resistant HCC.
Climate change and armed conflict rank among the strongest drivers of migration across Africa. A new study by researchers at Chungnam National University analyzes 20 years of data (1995–2015) from African nations, finding that climate adaptation—particularly improvements in agricultural productivity—significantly weakens migration pressures linked to drought and armed conflict. Higher adaptive capacity, including better water access, health systems, and infrastructure, moderates these effects most during overlapping crises.